These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31131464)

  • 21. Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice.
    Lang L; Li W; Guo N; Ma Y; Zhu L; Kiesewetter DO; Shen B; Niu G; Chen X
    Bioconjug Chem; 2011 Dec; 22(12):2415-22. PubMed ID: 22026940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors.
    Su X; Cheng K; Jeon J; Shen B; Venturin GT; Hu X; Rao J; Chin FT; Wu H; Cheng Z
    Mol Pharm; 2014 Nov; 11(11):3947-56. PubMed ID: 24972326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging.
    Xu Y; Pan D; Zhu C; Xu Q; Wang L; Chen F; Yang R; Luo S; Yang M; Yan Y
    Mol Imaging Biol; 2014 Aug; 16(4):578-85. PubMed ID: 24389931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker.
    Zhu C; Xu Q; Pan D; Xu Y; Liu P; Yang R; Wang L; Sun X; Luo S; Yang M
    Contrast Media Mol Imaging; 2016; 11(2):99-105. PubMed ID: 26286841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Kwon LY; Scollard DA; Reilly RM
    Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
    Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
    J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate-PEG-NOTA-Al
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and Characterization of a Novel PET Tracer for Noninvasive Evaluation of FGL1 Status in Tumors.
    Tan S; Ding X; Pan D; Xu Y; Wang C; Yan J; Chen C; Wang L; Wang X; Yang M; Xu Y
    Mol Pharm; 2024 Jul; 21(7):3425-3433. PubMed ID: 38836286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Al
    Qiao Z; Xu J; Gonzalez R; Miao Y
    Bioconjug Chem; 2022 May; 33(5):982-990. PubMed ID: 35475603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immuno-PET imaging of
    Liu Q; Jiang L; Li K; Li H; Lv G; Lin J; Qiu L
    Cancer Immunol Immunother; 2021 Jun; 70(6):1721-1733. PubMed ID: 33386467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models.
    Kang CM; Kim SM; Koo HJ; Yim MS; Lee KH; Ryu EK; Choe YS
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):198-206. PubMed ID: 23096079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
    J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Evaluation of a Novel
    Zhang H; Kanduluru AK; Desai P; Ahad A; Carlin S; Tandon N; Weber WA; Low PS
    Bioconjug Chem; 2018 Apr; 29(4):1319-1326. PubMed ID: 29466853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.
    Schoffelen R; Sharkey RM; Goldenberg DM; Franssen G; McBride WJ; Rossi EA; Chang CH; Laverman P; Disselhorst JA; Eek A; van der Graaf WT; Oyen WJ; Boerman OC
    Mol Cancer Ther; 2010 Apr; 9(4):1019-27. PubMed ID: 20354120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of
    Dahlsson Leitao C; Rinne SS; Mitran B; Vorobyeva A; Andersson KG; Tolmachev V; Ståhl S; Löfblom J; Orlova A
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syntheses and preliminary evaluation of [(18) F]AlF-NOTA-G-TMTP1 for PET imaging of high aggressive hepatocellular carcinoma.
    Li Y; Zhang D; Shi Y; Guo Z; Wu X; Ren JL; Zhang X; Wu H
    Contrast Media Mol Imaging; 2016 Jul; 11(4):262-71. PubMed ID: 26931574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
    Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
    Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Translation of [
    Xavier C; Blykers A; Laoui D; Bolli E; Vaneyken I; Bridoux J; Baudhuin H; Raes G; Everaert H; Movahedi K; Van Ginderachter JA; Devoogdt N; Caveliers V; Lahoutte T; Keyaerts M
    Mol Imaging Biol; 2019 Oct; 21(5):898-906. PubMed ID: 30671739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.